ArtivionvsThermo Fisher Scientific

AORT and TMO stock compared: price, dividend, valuation and results, from SEC filings.

AORT

Artivion, Inc.

$19.10

Value $915M

-1.55%
AORT's page

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Artivion (AORT) has a market value of $915M and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, AORT moved -59.9% and TMO +19.5%. Dividend yield: AORT none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AORT$915M

    TMO$260B

    TMO is 284 times AORT

  • Revenue, 12 months

    AORT$482M

    TMO$47.4B

    TMO is 98 times AORT

  • Net income, 12 months

    AORT-$18M

    TMO$7.1B

  • Operating margin

    AORT2.3%

    TMO17.9%

    15.6 points apart

  • ROIC

    AORT1.2%

    TMO8.2%

    7.0 points apart

  • P/E

    AORT–

    TMO36.8

  • Dividend yield

    AORT0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    AORT-5.6%

    TMO+11.8%

    17.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AORT-5.6%

TMO+11.8%

10020020222023202420252026
Returns by period
PeriodAORTWith dividendsTMOWith dividends
1 year since November 12, 2025-59.9%Price -59.9%+19.5%Price +19.1%
3 years since November 13, 2023+40.8%+12.1% a yearPrice +40.8%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021-5.6%-1.2% a yearPrice -5.6%+11.8%+2.3% a yearPrice +10.2%
10 years since November 15, 2016-0.8%-0.1% a yearPrice -0.8%+384.5%+17.1% a yearPrice +371.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AORTArtivionTMOThermo Fisher Scientific

Valuation

AORTTMO
Valuation
Price$19.10$700.22
Market value$915M$260B
Enterprise value (EV)$1.2B$295B
P/E–36.8
P/E, 5-year median–32.7
P/B2.14.8
EV/EBIT111.634.9
Free cash flow yield–2.9%

Results and growth

AORTTMO
Results and growth
Revenue, 12 months$482M$47.4B
Net income, 12 months-$18M$7.1B
Free cash flow, 12 months-$44M$7.6B
Earnings per share, 12 months-$0.36$18.96
Revenue growth, year on year13.6%3.9%
Revenue growth a year, past+11.8%over 5 years+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

AORTTMO
Margins and returns on capital
Gross margin63.3%–
Operating margin2.3%17.9%
Net margin-3.7%14.9%
ROIC1.2%8.2%
ROE-4.0%13.4%

Balance sheet

AORTTMO
Balance sheet
Cash$48M$6.1B
Total debt$407M$41.4B
Net debt / EBITDA9.53.7
Interest cover0.4×5.5×

Dividends and buybacks

AORTTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AORT or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Artivion or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 284.4 times Artivion ($915M), at today's prices.

How did AORT and TMO stock do over the last 10 years?

Since November 15, 2016, AORT's price moved -0.8% and TMO's +371.0%. With dividends: AORT -0.8% (-0.1% a year), TMO +384.5% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, AORT or TMO?

The dividend yield at today's price is none for Artivion and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Artivion or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -3.7% for Artivion and 14.9% for Thermo Fisher Scientific, and the operating margin 2.3% and 17.9%. Revenue was $482M and $47.4B.

Which is the better investment, Artivion or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.